Zobrazeno 1 - 10
of 936
pro vyhledávání: '"[SDV.MHEP.DERM] Life Sciences [q-bio]/Human health and pathology/Dermatology"'
Autor:
Malaure, Célie, Hoang, Stella, Bagny, Kelly, Tauziède-Espariat, Arnault, Garcia-Hermoso, Dea, Kamus, Laure, Traversier, Nicolas, Miltgen, Guillaume, Garrigos, Thomas
Publikováno v:
Journal of Dermatology
Journal of Dermatology, 2023, 50 (6), pp.e179-e180. ⟨10.1111/1346-8138.16706⟩
Journal of Dermatology, 2023, 50 (6), pp.e179-e180. ⟨10.1111/1346-8138.16706⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2100::05b5d118aa46d31286a9d2d177ee30b2
https://hal.univ-reunion.fr/hal-04104761
https://hal.univ-reunion.fr/hal-04104761
Autor:
Thibault Kervarrec, Eric Frouin, Christine Collin, Anne Tallet, Matthias Tallegas, Daniel Pissaloux, Franck Tirode, Serge Guyétant, Mahtab Samimi, Pauline Gaboriaud, Antoine Touzé, David Schrama, Roland Houben, Flore Tabareau‐Delalande, Anne Neuhart, Arnaud de la Fouchardière, Amélie Osio, Bénédicte Cavelier–Balloy, Sara Laurent‐Roussel, Pierre Sohier, Tilmant Cyprien, Brigitte Balme, Fanny Belzung, Marie‐Laure Jullie, Bernard Cribier, Maxime Battistella, Nicolas Macagno
Publikováno v:
Histopathology
Histopathology, 2023, 82 (6), pp.885-898. ⟨10.1111/his.14874⟩
Histopathology, 2023, 82 (6), pp.885-898. ⟨10.1111/his.14874⟩
International audience; Aims: Recently, YAP1 fusion genes have been demonstrated in eccrine poroma and porocarcinoma, and the diagnostic use of YAP1 immunohistochemistry has been highlighted in this setting. In other organs, loss of YAP1 expression c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eae65710c1973e0df707640f426d9b7b
https://hal.inrae.fr/hal-04077169/file/2023_Kervarrec_Histopathol_vol-82.pdf
https://hal.inrae.fr/hal-04077169/file/2023_Kervarrec_Histopathol_vol-82.pdf
Autor:
Rousset, Perrine, Dalle, Stéphane, Mortier, Laurent, Dereure, Olivier, Dalac, Sophie, Dutriaux, Caroline, Leccia, Marie-Thérèse, Legoupil, Delphine, Brunet-Possenti, Florence, de Quatrebarbes, Julie, Grob, Jean-Jacques, Saiag, Philippe, Maubec, Eve, Stoebner, Pierre-Emmanuel, Granel-Brocard, Florence, Arnault, Jean-Philippe, Allayous, Clara, Oriano, Bastien, Lebbé, Celeste, Montaudié, Henri
Publikováno v:
Journal of The American Academy of Dermatology
Journal of The American Academy of Dermatology, 2023, 88 (4), pp.808-815. ⟨10.1016/j.jaad.2022.11.040⟩
Journal of The American Academy of Dermatology, 2023, 88 (4), pp.808-815. ⟨10.1016/j.jaad.2022.11.040⟩
International audience; Background: Clinical outcomes of advanced melanoma of unknown primary (MUP) in the era of novel therapies have been scarcely studied.Objective: To investigate the efficacy and safety of systemic treatments in patients with adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710dbf1cc61bbf8b206c0b976465dba7
https://hal.science/hal-04052676
https://hal.science/hal-04052676
Autor:
Manuelle Viguier, Corine Pérals, Béatrice Poirier, Maxime Battistella, François Aubin, Hervé Bachelez, Jean‐Luc Prétet, Tarik Gheit, Massimo Tommasino, Antoine Touzé, Marie‐Lise Gougeon, Nicolas Fazilleau
Publikováno v:
Experimental Dermatology
Experimental Dermatology, 2023, 32 (6), pp.859-868. ⟨10.1111/exd.14788⟩
Experimental Dermatology, 2023, 32 (6), pp.859-868. ⟨10.1111/exd.14788⟩
International audience; Lichen planus (LP) is a cutaneomucosal chronic inflammatory disease characterized by a CD8 + cytotoxic T-lymphocytes (CTL) infiltrate. In erosive oral LP, we found HPV16specific activated CTL in lesions, supporting a pathogeni
Autor:
Davalos, Verónica, Lovell, Claudia, von Itter, Richard, Dolgalev, Igor, Agrawal, Praveen, Baptiste, Gillian, Kahler, David, Sokolova, Elena, Moran, Sebastian, Piqué, Laia, Vega-Saenz de Miera, Eleazar, Fontanals-Cirera, Barbara, Karz, Alcida, Tsirigos, Aristotelis, Yun, Chi, Darvishian, Farbod, Etchevers, Heather, Osman, Iman, Esteller, Manel, Schober, Markus, Hernando, Eva
Publikováno v:
Nature Communications
Nature Communications, In press, 14 (1), pp.1867. ⟨10.1038/s41467-023-36967-2⟩
Nature Communications, In press, 14 (1), pp.1867. ⟨10.1038/s41467-023-36967-2⟩
International audience; Metastatic melanoma develops once transformed melanocytic cells begin to de-differentiate into migratory and invasive melanoma cells with neural crest cell (NCC)-like and epithelial-tomesenchymal transition (EMT)-like features
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3430::84b36dc97288bc875930599b2fd98021
https://hal-amu.archives-ouvertes.fr/hal-04007075
https://hal-amu.archives-ouvertes.fr/hal-04007075
Publikováno v:
Cellular Biology. Université Paris sciences et lettres, 2022. English. ⟨NNT : 2022UPSLS024⟩
The mechanical, chemical, or infectious mediated tissue damages affect all epithelial barriers including the skin. The rapid resolution of theses damages is key to recover their integrity and function, it involves the joint action of several immune c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1398::26362c8fac91f1bcb35acb33ee4cbad6
https://theses.hal.science/tel-04021170/document
https://theses.hal.science/tel-04021170/document
Autor:
Arnaud Carrier, Cécile Desjobert, Loic Ponger, Laurence Lamant, Matias Bustos, Jorge Torres-Ferreira, Rui Henrique, Carmen Jeronimo, Luisa Lanfrancone, Audrey Delmas, Gilles Favre, Antoine Daunay, Florence Busato, Dave SB Hoon, Jorg Tost, Chantal Etievant, Joëlle Riond, Paola B Arimondo
Publikováno v:
eLife
eLife, 2022, 11, pp.e78587. ⟨10.7554/eLife.78587⟩
eLife, 2022, 11, pp.e78587. ⟨10.7554/eLife.78587⟩
Funder Grant reference number Author Centre National de la Recherche Scientifique Centre National de la Recherche Scientifique Centre National de la Recherche Scientifique ATIP Region Midi Pyrenees-Equipe d'excellence Region Midi Pyrenees-FEDER Paola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7088d8da6bc8a49e806a1d1dee81d0
https://hal.science/hal-03798060
https://hal.science/hal-03798060
Autor:
J. Delaleu, C. Lepelletier, A. Calugareanu, A. De Masson, E. Charvet, A. Petit, I. Giurgea, S. Amselem, S. Karabina, M. Jachiet, T. Mahevas, C. Ram-Wolff, M.-D. Vignon-Pennamen, M. Bagot, M. Battistella, J.-D. Bouaziz
Publikováno v:
La Revue de Médecine Interne
La Revue de Médecine Interne, 2022, pp.S0248-8663(22)00544-6. ⟨10.1016/j.revmed.2022.06.007⟩
La Revue de Médecine Interne, 2022, pp.S0248-8663(22)00544-6. ⟨10.1016/j.revmed.2022.06.007⟩
International audience; Neutrophilic dermatoses (ND) are a group of inflammatory skin conditions characterized by a neutrophilic infiltrate on histopathology with no evidence of infection. ND are classified based upon the localization of neutrophils
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c93327f34f2ed430504331e300f1ca42
https://www.hal.inserm.fr/inserm-03875233/file/1-s2.0-S0248866322005446-main.pdf
https://www.hal.inserm.fr/inserm-03875233/file/1-s2.0-S0248866322005446-main.pdf
Autor:
Laetitia Vercellino, Dorine de Jong, Laurent Dercle, Benoit Hosten, Brian Braumuller, Jeeban Paul Das, Aileen Deng, Antoine Moya-Plana, Camry A’Keen, Randy Yeh, Pascal Merlet, Barouyr Baroudjian, Mary M. Salvatore, Kathleen M. Capaccione
Publikováno v:
Diagnostics
Diagnostics, 2022, 12 (5), pp.1116. ⟨10.3390/diagnostics12051116⟩
Diagnostics, 2022, 12 (5), pp.1116. ⟨10.3390/diagnostics12051116⟩
International audience; Melanoma is a deadly disease that often exhibits relentless progression and can have both early and late metastases. Recent advances in immunotherapy and targeted therapy have dramatically increased patient survival for patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03faf799f4a5a6d3602edf2a4d224cd1
https://www.hal.inserm.fr/inserm-03924844
https://www.hal.inserm.fr/inserm-03924844
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, 2022, 12, pp.857572. ⟨10.3389/fonc.2022.857572⟩
Frontiers in Oncology, 2022, 12, pp.857572. ⟨10.3389/fonc.2022.857572⟩
Cutaneous melanoma is a highly invasive tumor and, despite the development of recent therapies, most patients with advanced metastatic melanoma have a poor clinical outcome. The most frequent mutations in melanoma affect the BRAF oncogene, a protein